IBDEI02U ; ; 12-JAN-2012
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JAN 12, 2012
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3487,1,4,0)
 ;;=4^238.79
 ;;^UTILITY(U,$J,358.3,3487,1,5,0)
 ;;=5^Lymph/Hematpoitc Tis Nec
 ;;^UTILITY(U,$J,358.3,3487,2)
 ;;=^334033
 ;;^UTILITY(U,$J,358.3,3488,0)
 ;;=287.30^^36^274^120
 ;;^UTILITY(U,$J,358.3,3488,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3488,1,4,0)
 ;;=4^287.30
 ;;^UTILITY(U,$J,358.3,3488,1,5,0)
 ;;=5^Primary Thrombocytopenia
 ;;^UTILITY(U,$J,358.3,3488,2)
 ;;=^332841
 ;;^UTILITY(U,$J,358.3,3489,0)
 ;;=288.09^^36^274^15
 ;;^UTILITY(U,$J,358.3,3489,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3489,1,4,0)
 ;;=4^288.09
 ;;^UTILITY(U,$J,358.3,3489,1,5,0)
 ;;=5^Agranulocytosis
 ;;^UTILITY(U,$J,358.3,3489,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,3490,0)
 ;;=284.81^^36^274^26
 ;;^UTILITY(U,$J,358.3,3490,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3490,1,4,0)
 ;;=4^284.81
 ;;^UTILITY(U,$J,358.3,3490,1,5,0)
 ;;=5^Aplastic Due To Drugs
 ;;^UTILITY(U,$J,358.3,3490,2)
 ;;=^335245
 ;;^UTILITY(U,$J,358.3,3491,0)
 ;;=284.89^^36^274^25
 ;;^UTILITY(U,$J,358.3,3491,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3491,1,4,0)
 ;;=4^284.89
 ;;^UTILITY(U,$J,358.3,3491,1,5,0)
 ;;=5^Aplastic Anemia due to Chr disease
 ;;^UTILITY(U,$J,358.3,3491,2)
 ;;=^87880
 ;;^UTILITY(U,$J,358.3,3492,0)
 ;;=284.9^^36^274^23
 ;;^UTILITY(U,$J,358.3,3492,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3492,1,4,0)
 ;;=4^284.9
 ;;^UTILITY(U,$J,358.3,3492,1,5,0)
 ;;=5^Aplastic Anemia NOS
 ;;^UTILITY(U,$J,358.3,3492,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,3493,0)
 ;;=289.84^^36^274^136
 ;;^UTILITY(U,$J,358.3,3493,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3493,1,4,0)
 ;;=4^289.84
 ;;^UTILITY(U,$J,358.3,3493,1,5,0)
 ;;=5^Thrombocytopenia,Heparin Induced
 ;;^UTILITY(U,$J,358.3,3493,2)
 ;;=^336542
 ;;^UTILITY(U,$J,358.3,3494,0)
 ;;=204.02^^36^274^12
 ;;^UTILITY(U,$J,358.3,3494,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3494,1,4,0)
 ;;=4^204.02
 ;;^UTILITY(U,$J,358.3,3494,1,5,0)
 ;;=5^ALL, In Relapse
 ;;^UTILITY(U,$J,358.3,3494,2)
 ;;=^336465
 ;;^UTILITY(U,$J,358.3,3495,0)
 ;;=204.12^^36^274^35
 ;;^UTILITY(U,$J,358.3,3495,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3495,1,4,0)
 ;;=4^204.12
 ;;^UTILITY(U,$J,358.3,3495,1,5,0)
 ;;=5^CLL, In Remission
 ;;^UTILITY(U,$J,358.3,3495,2)
 ;;=^336466
 ;;^UTILITY(U,$J,358.3,3496,0)
 ;;=204.21^^36^274^129
 ;;^UTILITY(U,$J,358.3,3496,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3496,1,4,0)
 ;;=4^204.21
 ;;^UTILITY(U,$J,358.3,3496,1,5,0)
 ;;=5^Subacute LL in Remission
 ;;^UTILITY(U,$J,358.3,3496,2)
 ;;=^267526
 ;;^UTILITY(U,$J,358.3,3497,0)
 ;;=204.20^^36^274^130
 ;;^UTILITY(U,$J,358.3,3497,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3497,1,4,0)
 ;;=4^204.20
 ;;^UTILITY(U,$J,358.3,3497,1,5,0)
 ;;=5^Subacute LL w/o Remission
 ;;^UTILITY(U,$J,358.3,3497,2)
 ;;=^336852
 ;;^UTILITY(U,$J,358.3,3498,0)
 ;;=204.22^^36^274^131
 ;;^UTILITY(U,$J,358.3,3498,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3498,1,4,0)
 ;;=4^204.22
 ;;^UTILITY(U,$J,358.3,3498,1,5,0)
 ;;=5^Subacute LL, in Relapse
 ;;^UTILITY(U,$J,358.3,3498,2)
 ;;=^336467
 ;;^UTILITY(U,$J,358.3,3499,0)
 ;;=203.02^^36^274^116
 ;;^UTILITY(U,$J,358.3,3499,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3499,1,4,0)
 ;;=4^203.02
 ;;^UTILITY(U,$J,358.3,3499,1,5,0)
 ;;=5^Multiple Myeloma,In Relapse
 ;;^UTILITY(U,$J,358.3,3499,2)
 ;;=^336462
 ;;^UTILITY(U,$J,358.3,3500,0)
 ;;=205.02^^36^274^13
 ;;^UTILITY(U,$J,358.3,3500,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3500,1,4,0)
 ;;=4^205.02
 ;;^UTILITY(U,$J,358.3,3500,1,5,0)
 ;;=5^AML, In Relapse
 ;;^UTILITY(U,$J,358.3,3500,2)
 ;;=^336470
 ;;^UTILITY(U,$J,358.3,3501,0)
 ;;=205.12^^36^274^36
 ;;^UTILITY(U,$J,358.3,3501,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3501,1,4,0)
 ;;=4^205.12
 ;;^UTILITY(U,$J,358.3,3501,1,5,0)
 ;;=5^CML, In Relapse
 ;;^UTILITY(U,$J,358.3,3501,2)
 ;;=^336471
 ;;^UTILITY(U,$J,358.3,3502,0)
 ;;=V10.91^^36^274^76
 ;;^UTILITY(U,$J,358.3,3502,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3502,1,4,0)
 ;;=4^V10.91
 ;;^UTILITY(U,$J,358.3,3502,1,5,0)
 ;;=5^H/O Neuroendocrine CA Tumor
 ;;^UTILITY(U,$J,358.3,3502,2)
 ;;=^338494
 ;;^UTILITY(U,$J,358.3,3503,0)
 ;;=V10.91^^36^274^86
 ;;^UTILITY(U,$J,358.3,3503,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3503,1,4,0)
 ;;=4^V10.91
 ;;^UTILITY(U,$J,358.3,3503,1,5,0)
 ;;=5^H/O Unspecified Malignant Neoplasm
 ;;^UTILITY(U,$J,358.3,3503,2)
 ;;=^338494
 ;;^UTILITY(U,$J,358.3,3504,0)
 ;;=465.9^^36^275^73
 ;;^UTILITY(U,$J,358.3,3504,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3504,1,4,0)
 ;;=4^465.9
 ;;^UTILITY(U,$J,358.3,3504,1,5,0)
 ;;=5^Uri
 ;;^UTILITY(U,$J,358.3,3504,2)
 ;;=URI^269878
 ;;^UTILITY(U,$J,358.3,3505,0)
 ;;=462.^^36^275^60
 ;;^UTILITY(U,$J,358.3,3505,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3505,1,4,0)
 ;;=4^462.
 ;;^UTILITY(U,$J,358.3,3505,1,5,0)
 ;;=5^Sore Throat
 ;;^UTILITY(U,$J,358.3,3505,2)
 ;;=^2653
 ;;^UTILITY(U,$J,358.3,3506,0)
 ;;=466.0^^36^275^3
 ;;^UTILITY(U,$J,358.3,3506,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3506,1,4,0)
 ;;=4^466.0
 ;;^UTILITY(U,$J,358.3,3506,1,5,0)
 ;;=5^Bronchitis,Acute
 ;;^UTILITY(U,$J,358.3,3506,2)
 ;;=^259084
 ;;^UTILITY(U,$J,358.3,3507,0)
 ;;=112.1^^36^275^78
 ;;^UTILITY(U,$J,358.3,3507,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3507,1,4,0)
 ;;=4^112.1
 ;;^UTILITY(U,$J,358.3,3507,1,5,0)
 ;;=5^Vulvovaginitis,Candidal
 ;;^UTILITY(U,$J,358.3,3507,2)
 ;;=^18615
 ;;^UTILITY(U,$J,358.3,3508,0)
 ;;=616.0^^36^275^13
 ;;^UTILITY(U,$J,358.3,3508,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3508,1,4,0)
 ;;=4^616.0
 ;;^UTILITY(U,$J,358.3,3508,1,5,0)
 ;;=5^Cervicitis
 ;;^UTILITY(U,$J,358.3,3508,2)
 ;;=^21925
 ;;^UTILITY(U,$J,358.3,3509,0)
 ;;=599.0^^36^275^74
 ;;^UTILITY(U,$J,358.3,3509,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3509,1,4,0)
 ;;=4^599.0
 ;;^UTILITY(U,$J,358.3,3509,1,5,0)
 ;;=5^Uti
 ;;^UTILITY(U,$J,358.3,3509,2)
 ;;=UTI^124436
 ;;^UTILITY(U,$J,358.3,3510,0)
 ;;=460.^^36^275^45
 ;;^UTILITY(U,$J,358.3,3510,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3510,1,4,0)
 ;;=4^460.
 ;;^UTILITY(U,$J,358.3,3510,1,5,0)
 ;;=5^Nasopharyngitis, Acute
 ;;^UTILITY(U,$J,358.3,3510,2)
 ;;=^26543
 ;;^UTILITY(U,$J,358.3,3511,0)
 ;;=372.30^^36^275^14
 ;;^UTILITY(U,$J,358.3,3511,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3511,1,4,0)
 ;;=4^372.30
 ;;^UTILITY(U,$J,358.3,3511,1,5,0)
 ;;=5^Conjunctivitis
 ;;^UTILITY(U,$J,358.3,3511,2)
 ;;=^27546
 ;;^UTILITY(U,$J,358.3,3512,0)
 ;;=595.9^^36^275^15
 ;;^UTILITY(U,$J,358.3,3512,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3512,1,4,0)
 ;;=4^595.9
 ;;^UTILITY(U,$J,358.3,3512,1,5,0)
 ;;=5^Cystitis
 ;;^UTILITY(U,$J,358.3,3512,2)
 ;;=^30304
 ;;^UTILITY(U,$J,358.3,3513,0)
 ;;=110.1^^36^275^16
 ;;^UTILITY(U,$J,358.3,3513,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3513,1,4,0)
 ;;=4^110.1
 ;;^UTILITY(U,$J,358.3,3513,1,5,0)
 ;;=5^Dermatophytosis Nail
 ;;^UTILITY(U,$J,358.3,3513,2)
 ;;=^33173
 ;;^UTILITY(U,$J,358.3,3514,0)
 ;;=562.11^^36^275^17
 ;;^UTILITY(U,$J,358.3,3514,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3514,1,4,0)
 ;;=4^562.11
 ;;^UTILITY(U,$J,358.3,3514,1,5,0)
 ;;=5^Diverticulitis
 ;;^UTILITY(U,$J,358.3,3514,2)
 ;;=^270274
 ;;^UTILITY(U,$J,358.3,3515,0)
 ;;=424.90^^36^275^18
 ;;^UTILITY(U,$J,358.3,3515,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3515,1,4,0)
 ;;=4^424.90
 ;;^UTILITY(U,$J,358.3,3515,1,5,0)
 ;;=5^Endocarditis
 ;;^UTILITY(U,$J,358.3,3515,2)
 ;;=^40327
 ;;^UTILITY(U,$J,358.3,3516,0)
 ;;=604.90^^36^275^19
 ;;^UTILITY(U,$J,358.3,3516,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3516,1,4,0)
 ;;=4^604.90
 ;;^UTILITY(U,$J,358.3,3516,1,5,0)
 ;;=5^Epididymitis
 ;;^UTILITY(U,$J,358.3,3516,2)
 ;;=^86178
 ;;^UTILITY(U,$J,358.3,3517,0)
 ;;=707.15^^36^275^21
 ;;^UTILITY(U,$J,358.3,3517,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3517,1,4,0)
 ;;=4^707.15
 ;;^UTILITY(U,$J,358.3,3517,1,5,0)
 ;;=5^Foot Ulcer
 ;;^UTILITY(U,$J,358.3,3517,2)
 ;;=^322148
 ;;^UTILITY(U,$J,358.3,3518,0)
 ;;=558.9^^36^275^22
 ;;^UTILITY(U,$J,358.3,3518,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3518,1,4,0)
 ;;=4^558.9
 ;;^UTILITY(U,$J,358.3,3518,1,5,0)
 ;;=5^Gastroenteritis
 ;;^UTILITY(U,$J,358.3,3518,2)
 ;;=^87311
 ;;^UTILITY(U,$J,358.3,3519,0)
 ;;=054.71^^36^275^33
 ;;^UTILITY(U,$J,358.3,3519,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3519,1,4,0)
 ;;=4^054.71
 ;;^UTILITY(U,$J,358.3,3519,1,5,0)
 ;;=5^Herpes Simplex, Mouth/Lip
 ;;^UTILITY(U,$J,358.3,3519,2)
 ;;=^266574
 ;;^UTILITY(U,$J,358.3,3520,0)
 ;;=054.10^^36^275^23
 ;;^UTILITY(U,$J,358.3,3520,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3520,1,4,0)
 ;;=4^054.10
 ;;^UTILITY(U,$J,358.3,3520,1,5,0)
 ;;=5^Genital Herpes, Unsp
 ;;^UTILITY(U,$J,358.3,3520,2)
 ;;=^56853
 ;;^UTILITY(U,$J,358.3,3521,0)
 ;;=098.0^^36^275^72
 ;;^UTILITY(U,$J,358.3,3521,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3521,1,4,0)
 ;;=4^098.0
 ;;^UTILITY(U,$J,358.3,3521,1,5,0)
 ;;=5^Urethritis,Gonococcal
 ;;^UTILITY(U,$J,358.3,3521,2)
 ;;=^52567
 ;;^UTILITY(U,$J,358.3,3522,0)
 ;;=054.13^^36^275^35
 ;;^UTILITY(U,$J,358.3,3522,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3522,1,4,0)
 ;;=4^054.13
 ;;^UTILITY(U,$J,358.3,3522,1,5,0)
 ;;=5^Herpetic Infect Of Penis
 ;;^UTILITY(U,$J,358.3,3522,2)
 ;;=^266560
 ;;^UTILITY(U,$J,358.3,3523,0)
 ;;=054.11^^36^275^36
 ;;^UTILITY(U,$J,358.3,3523,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3523,1,4,0)
 ;;=4^054.11
 ;;^UTILITY(U,$J,358.3,3523,1,5,0)
 ;;=5^Herpetic Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,3523,2)
 ;;=^57012
 ;;^UTILITY(U,$J,358.3,3524,0)
 ;;=053.9^^36^275^34
 ;;^UTILITY(U,$J,358.3,3524,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3524,1,4,0)
 ;;=4^053.9
 ;;^UTILITY(U,$J,358.3,3524,1,5,0)
 ;;=5^Herpes Zoster Nos
 ;;^UTILITY(U,$J,358.3,3524,2)
 ;;=^56946
 ;;^UTILITY(U,$J,358.3,3525,0)
 ;;=487.1^^36^275^39
 ;;^UTILITY(U,$J,358.3,3525,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3525,1,4,0)
 ;;=4^487.1
 ;;^UTILITY(U,$J,358.3,3525,1,5,0)
 ;;=5^Influenza
 ;;^UTILITY(U,$J,358.3,3525,2)
 ;;=^63125
